Phase I clinical trial of lobaplatin combined with image-guided volume-modulated arc radiation therapy in locally advanced cervical cancer
Jing You, Danning Wu, Jian Tie, Junyue Shen, Yidi Yuan, Xiaoxuan Gu, Weihu Wang, Xiaofan Li · 2026
Read Phase I clinical trial of lobaplatin combined with image-guided volume-modulated arc radiation therapy in locally advanced cervical cancer by Jing You, Danning Wu, Jian Tie, Junyue Shen, Yidi Yuan, Xiaoxuan Gu, Weihu Wang, Xiaofan Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13386611.txt.
Description
Jing You and co-authors published a phase one trial report in 2026 on pairing a chemotherapy drug with radiation for advanced cervical cancer. Early trials like this one seek the highest dose patients can tolerate. Patients had locally advanced disease and got beam radiation, internal radiation, and weekly doses of the drug lobaplatin. The dose rose step by step under a standard design.
Twenty-one patients joined between late 2020 and late 2022. Three had dose-limiting harms, and severe fatigue was the only serious non-blood harm of that kind. The highest tolerated weekly dose was set, and a slightly lower weekly dose was advised for use with radiation. The trial is complete and was registered before enrollment began.
Catalog record
| CREATOR | Jing You, Danning Wu, Jian Tie, Junyue Shen, Yidi Yuan, Xiaoxuan Gu, Weihu Wang, Xiaofan Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |